|Articles|June 1, 2018
- Pharmaceutical Executive-06-01-2018
- Volume 38
- Issue 6
Pharmaceutical Executive, June 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
US Maps Strategy to Reform Drug Pricingover 7 years ago
C-Suite Personality: Fit for Future?over 7 years ago
Insights for the Winover 7 years ago
Leveraging Lab Data in Advent of Personalized Marketingover 7 years ago
Asembia 2018: User-Friendly Urgencyover 7 years ago
Piecing Together the Pricing Puzzle: The Midterm Electionsover 7 years ago
Pharm Exec's Top 50 Companies 2018Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release
2
FDA Approves GSK's Exdensur as Twice-Yearly Add-On Therapy for Severe Asthma
3
Four Republicans Break with House GOP to Force Vote on Extending ACA Tax Credits
4
Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience
5